T. Danny Phillips serves as Executive at Caris Life Sciences, Inc., where they oversee executive responsibilities. Since joining the company, T. Danny Phillips has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 11, 2025 involved exercising options for 100,000 shares valued at $244.0K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Sep 11, 2025 | CAI | $244.0K | Option Exercise | 100,000 | $2.44 | Discretionary |
T. Danny Phillips currently holds 116,129 shares of Caris Life Sciences, Inc. (CAI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, T. Danny Phillips has been a net neutral trader of CAI stock. They have purchased $0 and sold $0 worth of shares.
T. Danny Phillips's most recent insider trade was on Sep 11, 2025, when they sold 100,000 shares at $2.44 per share.
Get notified when new Form 4 filings are submitted